Yong Ben
Fortune : 459 828 $ au 31/05/2026
Fortune : 459 828 $ au 31/05/2026
Actuellement, Yong Ben occupe le poste de directeur médical du département immunologie et oncologie de BeiGene Ltd. Le Dr Ben a obtenu un doctorat de l'université médicale Norman Bethune et un MBA de l'université de Californie à San Diego.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,06 % | 01/07/2026 | 44 576 ( 0,06 % ) | 399 847 $ | 31/05/2026 |
| 19/05/2026 | 7 583 ( 0,04 % ) | 59 982 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Directeur/Membre du Conseil | 01/03/2023 |
Eight Roads Capital Advisors (CHINA)
Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01/08/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| BEIGENE LTD | Directeur Technique/Scientifique/R&D | - |
| BIOATLA, INC. | Corporate Officer/Principal | 01/02/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Norman Bethune Medical University
Norman Bethune Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioAtla, Inc.
BioAtla, Inc. BiotechnologyHealth Technology Develops novel monoclonal antibody and protein therapeutic products | Health Technology |
Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Eight Roads Capital Advisors (CHINA)
Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Zonebourse is also available in this country: United States.
Switch edition